Literature DB >> 8885864

Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1)

B J Chambers1, M Salcedo, H G Ljunggren.   

Abstract

NK cell-mediated cytotoxicity is influenced by triggering as well as inhibitory signals. The identification of inhibitory signals provided by MHC class I molecules has recently attracted significant attention. Much less is known about putative triggering signals. Using purified populations of mouse NK cells, we demonstrate that the CD80 (B7-1) gene product functions as a triggering signal for NK cell-mediated cytotoxicity. The strength of this response is such that it overrides the protection mediated by MHC class I molecules. Triggering of mouse NK cells by B7-1 occurred even in the absence of CD28 and could not be blocked by either anti-CD28 or anti-CTLA-4 antibodies. NK cells may thus, at least in part, use receptors other than CD28 and CTLA-4 in their interaction with B7-1. Furthermore, we demonstrate that bone marrow-derived macrophages and dendritic cells are highly susceptible to lysis by autologous NK cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8885864     DOI: 10.1016/s1074-7613(00)80257-5

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  45 in total

1.  Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitro.

Authors:  S J Pettit; S Ali; E O'Flaherty; T R Griffiths; D E Neal; J A Kirby
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Mechanism of NK cell activation induced by coculture with dendritic cells derived from peripheral blood monocytes.

Authors:  Y Amakata; Y Fujiyama; A Andoh; K Hodohara; T Bamba
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

3.  Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer.

Authors:  E D Kwon; A A Hurwitz; B A Foster; C Madias; A L Feldhaus; N M Greenberg; M B Burg; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

4.  Critical role for perforin and Fas-dependent killing of dendritic cells in the control of inflammation.

Authors:  Min Chen; Kumar Felix; Jin Wang
Journal:  Blood       Date:  2011-10-31       Impact factor: 22.113

Review 5.  Regulation of natural killer cell function: a role for the NK cell's own MHC class I molecules.

Authors:  Werner Held; Anick Chalifour; Jérôme D Coudert
Journal:  Med Microbiol Immunol       Date:  2005-01-20       Impact factor: 3.402

6.  Transmission of Toxoplasma gondii from infected dendritic cells to natural killer cells.

Authors:  Catrine M Persson; Henrik Lambert; Polya P Vutova; Isabel Dellacasa-Lindberg; Joanna Nederby; Hideo Yagita; Hans-Gustaf Ljunggren; Alf Grandien; Antonio Barragan; Benedict J Chambers
Journal:  Infect Immun       Date:  2009-01-12       Impact factor: 3.441

7.  Lung and splenic B cells facilitate diverse effects on in vitro measures of antitumor immune responses.

Authors:  Harlan P Jones; Yi-Chong Wang; Beau Aldridge; Jay M Weiss
Journal:  Cancer Immun       Date:  2008-02-19

8.  Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology.

Authors:  Junwei Hao; Ruolan Liu; Wenhua Piao; Qinghua Zhou; Timothy L Vollmer; Denise I Campagnolo; Rong Xiang; Antonio La Cava; Luc Van Kaer; Fu-Dong Shi
Journal:  J Exp Med       Date:  2010-08-09       Impact factor: 14.307

9.  Expression of costimulatory molecules B7/CD28 in systemic lupus erythematosus.

Authors:  Shaoxian Hu; Deding Tao; Peigen He
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

10.  Impairment in natural killer cells editing of immature dendritic cells by infection with a virulent Trypanosoma cruzi population.

Authors:  Estela I Batalla; Agustina M Pino Martínez; Carolina V Poncini; Tomás Duffy; Alejandro G Schijman; Stella M González Cappa; Catalina D Alba Soto
Journal:  J Innate Immun       Date:  2013-05-08       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.